Annual revenue of Symphogen 2008-2018
The annual revenue of the Danish biotechnology company Symphogen fluctuated during the period from 2008 to 2018, with a peak in 2017, at around 290.7 million Danish kroner. In 2018, the annual revenue had decreased again, down to around 170.8 million Danish kroner.